Beacon Pointe Advisors, LLC - VISTAGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Beacon Pointe Advisors, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$16,000
-33.3%
19,0800.0%0.00%–
Q1 2022$24,000
-35.1%
19,0800.0%0.00%
-100.0%
Q4 2021$37,000
-28.8%
19,0800.0%0.00%0.0%
Q3 2021$52,000
-13.3%
19,0800.0%0.00%
-50.0%
Q2 2021$60,000–19,080–0.00%–
 Download
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders